REFRACTORY LEUKEMIA

Clinical trials for REFRACTORY LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug tested for Tough-to-Treat blood cancers

Disease control Ongoing

This is an early-stage study to find the safest dose of a new drug called tegavivint for adults with leukemia that has come back or stopped responding to standard treatments. The drug aims to block cancer cell growth, and researchers are testing it alone and with another drug, de…

Matched conditions: REFRACTORY LEUKEMIA

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY LEUKEMIA

Get alerted when new REFRACTORY LEUKEMIA trials appear

New drug tested for Tough-to-Treat blood cancers